Cart
sales@molnova.com
RWJ 63556
CAS No. 190967-35-2
RWJ 63556( RWJ-63556 )
Catalog No. M26425 CAS No. 190967-35-2
RWJ 63556 is an orally active inhibitor of COX-2 selective/5-lipoxygenase, shows anti-inflammatory activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 600 | Get Quote |
|
| 10MG | 1008 | Get Quote |
|
| 25MG | 1503 | Get Quote |
|
| 50MG | 2025 | Get Quote |
|
| 100MG | 2673 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRWJ 63556
-
NoteResearch use only, not for human use.
-
Brief DescriptionRWJ 63556 is an orally active inhibitor of COX-2 selective/5-lipoxygenase, shows anti-inflammatory activities.
-
DescriptionRWJ 63556 is an orally active inhibitor of COX-2 selective/5-lipoxygenase, shows anti-inflammatory activities.(In Vitro):RWJ 63556 is a potent leukocyte influx inhibitor over a period of 24 hr and maintains its in vitro profile on eicosanoids.(In Vivo):RWJ 63556 (1?mg/kg, i.v.) significantly inhibits the development of SP-induced oedema.
-
In VitroRWJ 63556 is a potent inhibitor of leukocyte influx over a period of 24 hr and maintains its in vitro profile on eicosanoids.
-
In VivoRWJ 63556 (1?mg/kg, i.v.) significantly inhibits the development of SP-induced oedema.
-
SynonymsRWJ-63556
-
PathwayImmunology/Inflammation
-
TargetLipoxygenase
-
RecptorVHL
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number190967-35-2
-
Formula Weight287.32
-
Molecular FormulaC11H10FNO3S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (348.03 mM)
-
SMILESCS(=O)(=O)Nc1ccc(Oc2ccc(F)cc2)s1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Pillow TH, et al. Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity. ChemMedChem. 2019 Oct 31.
molnova catalog
related products
-
Masoprocol
Masoprocol (meso-Nordihydroguaiaretic acid) is a potent, orally active lipoxygenase inhibitor that exhibits antihyperglycemic activity, making it potentially valuable for type II diabetes research. In vivo, Masoprocol reduces glucose and hepatic triglyceride concentrations .
-
CBS-1114 HCl
CBS-1114 HCl (N-Phenylbenzamidrazone hydrochloride) is a 5-lipoxygenase inhibitor and an anti-inflammatory compound in a good eye-permeable model.
-
BW 755C
BW 755C is a dual inhibitor of 5-lipoxygenase (5-LO) and cyclooxygenase (COX) pathways.
